Originalspråkengelska
TidskriftHaematologica
Volym104
Utgåva2
Sidor (från-till)338-346
Antal sidor9
ISSN0390-6078
DOI
StatusPublicerad - feb 2019
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3121 Inre medicin
  • 3111 Biomedicinska vetenskaper

Citera det här

@article{9818cc75be8b44e889f7f31247ec9848,
title = "T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma",
keywords = "CLASS-II EXPRESSION, INACTIVATION, RITUXIMAB, ANTIBODY, BLINATUMOMAB, LYMPHOCYTES, IPILIMUMAB, SURVIVAL, FEATURES, GENES, 3121 Internal medicine, 3111 Biomedicine",
author = "Suvi-Katri Leivonen and Marjukka Pollari and Oscar Br{\"u}ck and Teijo Pellinen and Matias Autio and Marja-Liisa Karjalainen-Lindsberg and Susanna Mannisto and Pirkko-Liisa Kellokumpu-Lehtinen and Olli Kallioniemi and Satu Mustjoki and Sirpa Lepp{\"a}",
year = "2019",
month = "2",
doi = "10.3324/haematol.2018.200105",
language = "English",
volume = "104",
pages = "338--346",
journal = "Haematologica",
issn = "0390-6078",
publisher = "FERRATA STORTI FOUNDATION",
number = "2",

}

TY - JOUR

T1 - T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma

AU - Leivonen, Suvi-Katri

AU - Pollari, Marjukka

AU - Brück, Oscar

AU - Pellinen, Teijo

AU - Autio, Matias

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Mannisto, Susanna

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

AU - Kallioniemi, Olli

AU - Mustjoki, Satu

AU - Leppä, Sirpa

PY - 2019/2

Y1 - 2019/2

KW - CLASS-II EXPRESSION

KW - INACTIVATION

KW - RITUXIMAB

KW - ANTIBODY

KW - BLINATUMOMAB

KW - LYMPHOCYTES

KW - IPILIMUMAB

KW - SURVIVAL

KW - FEATURES

KW - GENES

KW - 3121 Internal medicine

KW - 3111 Biomedicine

U2 - 10.3324/haematol.2018.200105

DO - 10.3324/haematol.2018.200105

M3 - Article

VL - 104

SP - 338

EP - 346

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 2

ER -